ArticleJHEP reports : innovation in hepatology2026

Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction.

Bridget P Keenan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.